Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00886470 · ClinicalTrials.gov registry record · Phase 1
ST266 Versus Standard Care In Treating Partial Thickness Burns
A Phase 1 study, sponsored by Noveome Biotherapeutics, formerly Stemnion.
- Terminated
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT00886470 is a Phase 1 study that was terminated before completion, run by Noveome Biotherapeutics, formerly Stemnion. The registered enrollment target is 16 participants.
The verdict
NCT00886470, a Phase 1 study, was terminated before completion, sponsored by Noveome Biotherapeutics, formerly Stemnion.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The objective of this protocol is to perform a safety and dose-determination efficacy clinical trial in patients having a degree of partial-thickness burn wounds. The trial will be a prospectively randomized and double-blind trial of ST266 compared with standardized care using 0.9% NaCl (normal saline) solution in the same three treatment regimens.
Interventions
- BIOLOGICAL ST266
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00886470
The ClinicalTrials.gov registry entry for NCT00886470 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Noveome Biotherapeutics, formerly Stemnion, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ST266 is the first listed.
NCT00886470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00886470 about?
NCT00886470 is a clinical study titled "ST266 Versus Standard Care In Treating Partial Thickness Burns". The objective of this protocol is to perform a safety and dose-determination efficacy clinical trial in patients having a degree of partial-thickness burn wounds. The trial will be a prospectively randomized and double-blind trial of ST266 compared with standardized care using 0.9% NaCl (normal sali...
What is the current status of trial NCT00886470?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2009-06. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00886470?
The interventions under investigation include: ST266 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00886470?
This trial is sponsored by Noveome Biotherapeutics, formerly Stemnion, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.